Literature DB >> 15521854

Review article: the overlap between functional dyspepsia and irritable bowel syndrome -- a tale of one or two disorders?

F Cremonini1, N J Talley.   

Abstract

Functional dyspepsia and irritable bowel syndrome are currently considered to be two separate nosological entities. However, the overlap of symptoms and the evidence of a number of common pathophysiological characteristics suggest that functional dyspepsia and irritable bowel syndrome may be different presentations of the same disorder. In this review, we critically appraise points in common, as well as differences, in the epidemiology, pathophysiology and response to treatment of functional dyspepsia and irritable bowel syndrome. Population-based studies and large case series show that one- to two-thirds of subjects with irritable bowel syndrome have symptoms that overlap with functional dyspepsia. Symptom analyses have generally failed to support functional dyspepsia and irritable bowel syndrome as separate entities. An exaggerated motor response to meals, delayed gastric emptying and abnormal small bowel and colonic transit can all be found in subsets of functional dyspepsia and irritable bowel syndrome, and are not exclusive to either condition. Visceral hypersensitivity is a common feature to both entities and seems unlikely to be site or disease specific. There is good evidence for the post-infectious development of irritable bowel syndrome, and this may also apply in functional dyspepsia. Psychiatric comorbidities are similar in functional dyspepsia and irritable bowel syndrome. Several common drug classes (prokinetics, visceral analgesics, psychoactive agents) may similarly improve both functional dyspepsia and irritable bowel syndrome symptoms. The evidence available suggests that at least subsets of functional dyspepsia and irritable bowel syndrome represent different manifestations of a single entity. The identification of common pathophysiological targets for therapy should be pursued in future research.

Entities:  

Mesh:

Year:  2004        PMID: 15521854     DOI: 10.1111/j.1365-2036.2004.02184.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  19 in total

Review 1.  Irritable bowel syndrome and functional dyspepsia: different diseases or a single disorder with different manifestations?

Authors:  Laura Noddin; Michael Callahan; Brian E Lacy
Journal:  MedGenMed       Date:  2005-08-29

2.  Racial differences in epidemiology of irritable bowel syndrome alone, un-investigated dyspepsia alone, and "overlap syndrome" among african americans compared to Caucasians: a population-based study.

Authors:  Anil Minocha; William Chad; Wigington Do; William D Johnson
Journal:  Dig Dis Sci       Date:  2006-01       Impact factor: 3.199

3.  Bad language in gastroenterology.

Authors:  Fergus Shanahan; Eamonn M M Quigley
Journal:  Curr Gastroenterol Rep       Date:  2008-04

Review 4.  Symptom overlap and comorbidity of irritable bowel syndrome with other conditions.

Authors:  Christine L Frissora; Kenneth L Koch
Journal:  Curr Gastroenterol Rep       Date:  2005-08

Review 5.  Frontiers in functional dyspepsia.

Authors:  Noel R Fajardo; Filippo Cremonini; Nicholas J Talley
Journal:  Curr Gastroenterol Rep       Date:  2005-08

6.  Itopride in the treatment of functional dyspepsia in Chinese patients: a prospective, multicentre, post-marketing observational study.

Authors:  Jing Sun; Yao-Zong Yuan; Gerald Holtmann
Journal:  Clin Drug Investig       Date:  2011-12-01       Impact factor: 2.859

7.  Validation of Self-administrated Questionnaire for Psychiatric Disorders in Patients with Functional Dyspepsia.

Authors:  Ada W Y Tse; Larry H Lai; C C Lee; Kelvin K F Tsoi; Vincent W S Wong; Yawen Chan; Joseph J Y Sung; Francis K L Chan; Justin C Y Wu
Journal:  J Neurogastroenterol Motil       Date:  2010-01-31       Impact factor: 4.924

8.  Analysis of the gastrointestinal symptoms of uninvestigated dyspepsia and irritable bowel syndrome.

Authors:  Kazutoshi Hori; Takayuki Matsumoto; Hiroto Miwa
Journal:  Gut Liver       Date:  2009-09-30       Impact factor: 4.519

9.  Tegaserod for dyspepsia and reflux symptoms in patients with chronic constipation: an exploratory open-label study.

Authors:  Juan Zeng; Xiu-Li Zuo; Yan-Qing Li; Wei Wei; Guo-Ping Lv
Journal:  Eur J Clin Pharmacol       Date:  2007-03-20       Impact factor: 2.953

10.  Exploratory Study of Tegaserod for Dyspepsia in Women Receiving PPIs for Heartburn.

Authors:  Nimish Vakil; Farid Kianifard; Ivan Bottoli
Journal:  Arch Drug Inf       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.